Tag

Advertisement

cantargia

Göran Forsberg Photo Håkan Sandbring

Cantargia reports encouraging results

March 2, 2022

Cantargia has reported new encouraging …

Göran Forsberg Photo Håkan Sandbring

Cantargia reports treatment of first triple negative breast cancer patient

January 25, 2022

Cantargia has reported treatment of …

Göran Forsberg Photo Håkan Sandbring

Cantargia receives positive opinion from EMA (COMP)

October 19, 2021

Cantargia has announced that the …

Göran Forsberg Photo Håkan Sandbring

Cantargia receives approval to start clinical study

September 15, 2021

Cantargia receives regulatory approval to …

Göran Forsberg, CEO, Cantargia

Cantargia expands CIRIFOUR trial

August 25, 2021

The company expands the trial …

Göran Forsberg, CEO, Cantargia

Cantargia submits clinical trial application

August 5, 2021

Cantargia has announced the submission …

Göran Forsberg, CEO, Cantargia

Cantargia broadens the development of nadunolimab

July 12, 2021

Cantargia has announced that the …

cantargia-goran

Cantargia announces positive trial results

May 25, 2021

The company has reported positive …

Göran Forsberg, CEO, Cantargia

Cantargia has completed a directed share issue of approximately SEK 564 million

December 16, 2020

Investors in the Directed Share …

Martin Welschof

BioInvent and Cantargia sign manufacturing agreement

December 11, 2020

Cantargia and BioInvent International have …

Göran Forsberg, CEO, Cantargia

Cantargia reports new trial results and presents next development steps

September 24, 2020

Cantargia has announced updated interim …

Göran Forsberg, CEO, Cantargia

Cantargia’s IND application for CAN04 approved by FDA

May 4, 2020

Cantargia has announced that its …

Cantargia

Cantargia acquires Cellerant IP on IL1RAP

March 12, 2020

Cantargia has announced the acquisition …

Cantargia

Cantargia completes a directed share issue of approximately 410 million SEK

February 20, 2020

Through the Directed Share Issue, …

cantargia

Cantargia selects CAN10 as development project in systemic sclerosis and myocarditis

December 12, 2019

Cantargia has announced that its …

Cantargia

An opposition has been filed against one of Cantargia’s patents

October 16, 2019

An opposition has been filed …

1
2